ImproveCareNow: The Development of a Pediatric Inflammatory Bowel Disease Improvement Network
Published January 17, 2011
Kappelman MD, Crandall WV, Colletti RB, Goudie A, Leibowitz IH, Duffy, Crandall W, Kappelman MD, Colletti RB, Leibowitz I, Grunow JE, Ali S, Baron HI, Berman JH, Boyle B, Cohen S, del Rosario F, Denson LA, Duffy L, Integlia MJ, Kim SC, Milov D, Patel AS, Schoen BT, Walkiewicz D, Margolis P. ImproveCareNow: the development of a pediatric IBD improvement network. Inflamm Bowel Dis 2011;17:450‐7
There is significant variation in diagnostic testing and treatment for inflammatory bowel disease. Quality improvement science methods can help address unwarranted variations in care and outcomes.
Short Pediatric Crohn’s Disease Activity Index for Quality Improvement and Observational Research
Published January 17, 2011
Kappelman MD, Crandall WV, Colletti RB, Goudie A, Leibowitz IH, Duffy L, Milov DE, Kim SC, Schoen BT, Patel AS, Grunow J, Larry E, Fairbrother G, Margolis P, ImproveCareNow Collaborative. Short pediatric Crohn’s disease activity index for quality improvement and observational research. Inflamm Bowel Dis 2011;17:112–117
Practical and objective instruments to assess pediatric Crohn’s disease (CD) activity are required for observational research and quality improvement. The objectives were: 1) to determine the feasibility of completing the Pediatric Crohn’s Disease Activity Index (PCDAI) and the Abbreviated PCDAI (APCDAI); and 2) to create a Short PCDAI by retaining and reweighting the most practical and informative components.
Development of process and outcome measures for improvement: Lessons learned in a quality improvement collaborative for pediatric Inflammatory Bowel Disease
Published March 2011
Crandall WV, Boyle BM, Colletti RB, Margolis PA, Kappelman MD. Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease. Inflamm Bowel Dis 2011;17:2184–219
The Institute of Medicine's publications, To Err is Human and Crossing the Quality Chasm, publicized the widespread deficits in healthcare quality. The quality of care in inflammatory bowel disease (IBD) has not been comprehensively evaluated, in part due to a lack of well-established IBD measures of quality.
Prevalence and Epidemiology of Overweight and Obesity in Children with Inflammatory Bowel Disease
Published October 17, 2011
Long MD, Crandall W, Leibowitz IH, Duffy L, del Rosario F, Kim SC, Integlia M, Berman J, Grunow J, Colletti RB, Schoen BT, Patel AS, Baron H, Israel E, Russell G, Ali S, Herfarth HH, Martin C, Kappelman MD. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:2162–2168
Obesity is a significant public health threat to children in the United States. The aims were to: 1) Determine the prevalence of obesity in a multicenter cohort of children with inflammatory bowel disease (IBD); 2) Evaluate whether overweight and obese status is associated with patient demographics or disease characteristics.